Royce & Associates LP Boosts Stake in Pediatrix Medical Group, Inc. (NYSE:MD)

Royce & Associates LP increased its position in Pediatrix Medical Group, Inc. (NYSE:MD) by 4.4% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 206,083 shares of the company’s stock after purchasing an additional 8,711 shares during the period. Royce & Associates LP’s holdings in Pediatrix Medical Group were worth $2,704,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the company. Rubric Capital Management LP lifted its position in shares of Pediatrix Medical Group by 1.5% in the third quarter. Rubric Capital Management LP now owns 8,275,000 shares of the company’s stock worth $95,907,000 after buying an additional 125,000 shares in the last quarter. State Street Corp lifted its position in shares of Pediatrix Medical Group by 1.4% in the third quarter. State Street Corp now owns 3,540,791 shares of the company’s stock worth $41,038,000 after buying an additional 50,597 shares in the last quarter. Pacer Advisors Inc. purchased a new stake in shares of Pediatrix Medical Group in the fourth quarter worth about $35,492,000. Geode Capital Management LLC lifted its position in shares of Pediatrix Medical Group by 2.4% in the third quarter. Geode Capital Management LLC now owns 1,936,751 shares of the company’s stock worth $22,452,000 after buying an additional 45,155 shares in the last quarter. Finally, Weiss Asset Management LP lifted its position in shares of Pediatrix Medical Group by 50.5% in the third quarter. Weiss Asset Management LP now owns 912,818 shares of the company’s stock worth $10,580,000 after buying an additional 306,143 shares in the last quarter. 97.71% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research firms recently commented on MD. UBS Group boosted their target price on Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a “neutral” rating in a research report on Friday, February 21st. StockNews.com raised Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research note on Wednesday, January 22nd. Truist Financial boosted their price objective on Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a “hold” rating in a research note on Friday, February 21st. Finally, Macquarie began coverage on Pediatrix Medical Group in a research note on Monday, December 16th. They set an “outperform” rating and a $18.00 price objective on the stock. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $17.08.

Pediatrix Medical Group Trading Down 0.8 %

MD opened at $14.12 on Friday. The stock has a market cap of $1.21 billion, a price-to-earnings ratio of -11.76, a P/E/G ratio of 1.74 and a beta of 1.49. The stock’s 50 day moving average price is $14.28 and its 200-day moving average price is $13.49. Pediatrix Medical Group, Inc. has a one year low of $6.62 and a one year high of $17.67. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.42 and a current ratio of 1.60.

Pediatrix Medical Group (NYSE:MD) last released its earnings results on Thursday, February 20th. The company reported $0.49 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.12. The firm had revenue of $502.36 million for the quarter, compared to analysts’ expectations of $486.22 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. On average, equities analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.